SCHEMBL6504605

SCHEMBL6504605

O=C(Nc1nc2c(CCN3CCOCC3)cccc2[nH]c1=O)c1cccc(Cl)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 3/20 0.44
KDM4E B2RXH2 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
MAPT P10636 2/20 0.44
HSD17B10 Q99714 2/20 0.44
TP53 P04637 2/20 0.44
MAPK1 P28482 1/20 0.44
DYRK1A Q13627 1/20 0.44
PARP1 P09874 2/20 0.43
ALDH1A1 P00352 2/20 0.43
LMNA P02545 1/20 0.43
ALOX15 P16050 1/20 0.43
HTT P42858 1/20 0.43
GAA P10253 1/20 0.43
AURKB Q96GD4 2/20 0.42
AURKA O14965 1/20 0.42
JAK2 O60674 1/20 0.42
JAK3 P52333 1/20 0.42
EPHX2 P34913 1/20 0.41
NPC1 O15118 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6509590 0.91 KDM4E (0.49) KDM4ESMN1; SMN2MAPTHSD17B10PARP1
SCHEMBL6505871 0.91 PARP1 (0.45) KDM4EHSD17B10MAPK1DYRK1APARP1
SCHEMBL6508473 0.85 MAPK1 (0.46) KDM4ESMN1; SMN2MAPTHSD17B10MAPK1
SCHEMBL17731555 0.75 IRAK4 (0.56) KDM4ESMN1; SMN2ALDH1A1LMNAGAA
SCHEMBL6500237 0.73 KDM4E (0.62) KDM4ESMN1; SMN2HSD17B10MAPK1LMNA
SCHEMBL6683837 0.70 NPC1 (0.63) KDM4ESMN1; SMN2MAPTLMNAHTT
SCHEMBL6644132 0.69 RAB9A (0.43) KDM4EMAPTHSD17B10MAPK1PARP1
SCHEMBL17554100 0.68 HTT (0.75) ALDH1A1HTTGAAEPHX2MEN1
SCHEMBL11711021 0.66 KDM4E (0.73) KDM4ESMN1; SMN2HSD17B10MAPK1LMNA
Hydrochloric Acid SCHEMBL8814898 0.66 GRIN2B (0.59) KDM4EHSD17B10TP53MAPK1PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005021547-A2 HETEROCYCLIC CANNABINOID CB2 RECEPTOR ANTAGONISTS PHARMAXIS PTY LTD. (AU) 2005-03-10 WO disclosed